USANA acquires 78.8% stake in Hiya Health for $205M; Hiya had $103M sales, $22M adjusted EBITDA LTM

USANA HEALTH SCIENCES INC

Acquired 78.8% controlling stake in Hiya Health for $205M cash; closed Dec 23, 2024.
Hiya's LTM (Sept 30, 2024) net sales $103M, net income $19M, adjusted EBITDA $22M.
Hiya serves 200,000+ customers via DTC subscription; net sales grew 50% in 2024 vs 2023.
Transaction expected to be immediately accretive to USANA's 2025 adjusted EBITDA.
Remaining 21.15% rollover equity subject to put/call based on Hiya's future EBITDA; financed from $200M cash on hand and credit facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.